Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Human CCKBR Anticorps:
anti-Rat (Rattus) CCKBR Anticorps:
anti-Mouse (Murine) CCKBR Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Human Polyclonal CCKBR Primary Antibody pour IHC, ELISA - ABIN185407
Olszewska-Pazdrak, Townsend, Hellmich: Agonist-independent activation of Src tyrosine kinase by a cholecystokinin-2 (CCK2) receptor splice variant. dans The Journal of biological chemistry 2004
Show all 5 Pubmed References
Cow (Bovine) Polyclonal CCKBR Primary Antibody pour EIA, IHC (p) - ABIN372564
El-Kouhen, Morisset: Cholecystokinin and Somatostatin Negatively Affect Growth of the Somatostatin-RIN-14B Cells. dans International journal of endocrinology 2009
Show all 2 Pubmed References
Human Polyclonal CCKBR Primary Antibody pour IF (p), IHC (p) - ABIN734318
Mohammad, Ozaki, Takeuchi, Unno, Yamoto, Morioka, Takiguchi, Ikeda: Functional compensation between cholecystokinin-1 and -2 receptors in murine paraventricular nucleus neurons. dans The Journal of biological chemistry 2012
Show all 2 Pubmed References
Human Polyclonal CCKBR Primary Antibody pour ICC, IF - ABIN251249
Berna, Seiz, Nast, Benten, Bläker, Koch, Lohse, Pace: CCK1 and CCK2 receptors are expressed on pancreatic stellate cells and induce collagen production. dans The Journal of biological chemistry 2010
Show all 2 Pubmed References
We concluded that low serum gastrin (Montrer GAST Anticorps) is related to increased risk of ER(+) BC development. The results also established that CCKBR/ERK (Montrer EPHB2 Anticorps)/P65 (Montrer GORASP1 Anticorps) signaling function is generally tumor suppressive in ER(+) BC, indicating therapies should focus on restoring, not inhibiting, CCKBR/ERK (Montrer EPHB2 Anticorps)/P65 (Montrer GORASP1 Anticorps) pathway activity.
High CCK2R expression is associated with cancer.
These results suggest that Z-360 exerts an anti-tumor effect through a reduction in anti-apoptosis factors by blocking CCK2R
High CCK-BR expression is associated with Gastric Cancer.
There is no identifiable link between nuclear CCK2R expression and all the clinicopathological characteristics examined in a cohort of Taiwanese colon cancer patients.
Our study showed significantly higher expression of CCKAR (Montrer CCKAR Anticorps) and down regulation of CCKBR in pancreatic cancer as compared to control while CCKBR/GR was detected in majority of stomach cancer samples. Thus, our study suggests that CCK (Montrer CCK Anticorps) and Gs receptors may have diagnostic and therapeutic implications.
Data indicate that variant c.811+32C>A in cholecystokinin-B receptor gene (CCKBR) does not have a significant impact on pancreatic cancer risk or survival in a Hungarian cohort.
The neurotransmitter cholecystokinin (CCK (Montrer CCK Anticorps)), along with its receptors, CCKAR (Montrer CCKAR Anticorps) and CCKBR, have been previously associated with psychiatric disorders, suggesting that variants near these genes may play a role in the pre-pulse/startle response in this cohort
There is functional synergy between cholecystokinin (Montrer CCK Anticorps) receptors CCKAR (Montrer CCKAR Anticorps) and CCKBR in mammalian brain development.
CCK-BR SNP predicts survival and should be studied as a candidate genetic biomarker for those at risk of pancreatic cancer.
Our data suggest a progression model for BE to EAC (Montrer CYLD Anticorps) in which CCK2R+ progenitor cells, stimulated by hypergastrinemia, proliferate to give rise to metaplasia and dysplasia.
CCKBR and D5R synergistically interact in the kidney, which may contribute to the maintenance of normal sodium balance following an increase in sodium intake
findings provide novel evidence that Cnr1 (Montrer CNR1 Anticorps) contributes to cued fear expression via an interaction with the CCKB receptor.
mice lacking CCK (Montrer CCK Anticorps) receptors exhibited a functional shift from the gastrin (Montrer GAST Anticorps)-CCK (Montrer CCK Anticorps) pathways to the neuronal pathway in control of the ECL (Montrer APOC4 Anticorps) cells and eventually the acid secretion
CCK2R labels +4 antral stem cells that can be activated and expanded by progastrin, thus identifying one hormonal trigger for gastric stem cell interconversion and a potential target for gastric cancer chemoprevention and therapy.
CCK-1 (Montrer CCL28 Anticorps) and -2 receptors may function synergistically in single PaPo neurons and deletion of CCK-1 (Montrer CCL28 Anticorps) receptors may facilitate CCK (Montrer CCK Anticorps)-2 receptor signaling.
cholecystokinin receptor-2 has a role in stress-triggered fear memory and anxiety in the mouse
shift of breakpoint on Arrhenius plot established in CCK (Montrer CCK Anticorps)(2) receptor-deficiency confirms that such kind of alteration in Na(+),K(+)-ATPase (Montrer ATP1A1 Anticorps) temperature dependence is likely related to the homeostatic adjustment of altered function of the sodium pump.
Environmental enrichment has beneficial effects in neuropathic conditions and reinforce the causal link between CCK(2) receptors, mechanical sensitivity and the development of CCI-induced hypersensitivity.
This gene encodes a G-protein coupled receptor for gastrin and cholecystokinin (CCK), regulatory peptides of the brain and gastrointestinal tract. This protein is a type B gastrin receptor, which has a high affinity for both sulfated and nonsulfated CCK analogs and is found principally in the central nervous system and the gastrointestinal tract. A misspliced transcript variant including an intron has been observed in cells from colorectal and pancreatic tumors.
cholecystokinin B receptor
, gastrin/cholecystokinin type B receptor
, CCK-B receptor
, CCK2 receptor
, cholecystokinin-2 receptor
, gastrin receptor
, CCK(B) receptor
, CCK-B/gastrin receptor
, CCK2/gastrin receptor
, Cholecystokinin-2 receptor
, gastrin/CCK-B receptor
, cholecystokinin receptor